Skip to content

Feasibility of a Video-oculography in Patients With Huntington's Disease VOG-HD Study

Feasibility of a Video-oculography in Patients With Huntington's Disease VOG-HD Study

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02563418
Acronym
VOG-HD
Enrollment
60
Registered
2015-09-30
Start date
2014-05-31
Completion date
Unknown
Last updated
2015-09-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Huntington Disease

Keywords

video oculography

Brief summary

The purpose of this study is to know the limits of feasibility of a reliable oculomotor record for patient with Huntington's disease.

Interventions

Sponsors

University Hospital, Angers
Lead SponsorOTHER_GOV

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Corrected visual acuity \>1/10 * Aged over 18 years * Patient with the mutation that is to say the presence of an abnormal number of trinuclide: CAG\> 38 in the first exon of the huntingtin gene. * Total Functional Capacity Scale (CFT) ≥ 3

Exclusion criteria

* Patients or trustworthy person who have not given their written consent, informed and signed. * Patients are not affiliated or who are not entitled to Social Security * Private patients of liberty by administrative or judicial decision, or patients supervision * Associated disease with neurological repercussions

Design outcomes

Primary

MeasureTime frameDescription
saccadic measures with the eye tracker1 dayone measure in the evening and one in the afternoon

Countries

France

Contacts

Primary ContactSophie Hue
sophie.hue@chu-angers.fr33 (0)241353800

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026